Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Use cases for Economic vs Market Index show when to rely on each signal, aiding risk assessment, timing, and portfolio adjustments.
28,511 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Insider sales by a bank CEO can raise questions. This article breaks down what a move like 'live bancshares sells ano...
As AI and HPC demand accelerates, investors are shifting away from Intel toward foundry and lithography peers. This p...
CarMax shares surged on Thursday after a rough session, driven by analyst upgrades and better-than-expected results. ...
Turning Point Brands stock has fallen today even after a strong quarterly report. This article explains what happened...
A major institutional move grabs attention as landmark investment partners cuts its stake in Howard Hughes Holdings. ...
The FDA approved bemotrizinol for over-the-counter sunscreen use on June 9, 2026, introducing the first new ingredien...
MongoDB stock is under pressure again, with shares dropping sharply amid a broad market sell-off. This article breaks...
Lenders grapple with how to price loans as multiple credit-score models collide, creating wide score gaps and complex...
Rocket Lab has been on a volatile ride as the space economy evolves. This guide explains why rocket stock keeps dropp...
Kalshi and Polymarket are reportedly exploring rounds that could push each platform toward $20 billion valuations, up...
Fairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...